Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Acelity Holdings, Inc. - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10369
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acelity Holdings Inc (Acelity) is a medical technology company engaged in developing wound care and regenerative medicine solutions. The company offers various solutions such as incision management, open abdomen management, epidermal harvesting and animal health. Acelity through its subsidiaries is involved in marketing several technology platforms such as negative pressure wound therapy (NPWT), surgical and incision management and epidermal grafting for patients suffering from traumatic, surgical and chronic wounds. The company also offers tissue matrices for reconstructive procedures such as post-mastectomy breast reconstruction and the reinforcement of abdominal wall defects. Acelity operates in the US and it is headquartered in San Antonio, Texas.

Acelity Holdings, Inc. – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acelity Holdings, Inc. , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acelity Holdings, Inc. , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Acelity Holdings, Inc. , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acelity Holdings, Inc. , Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Acelity Holdings, Inc. , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Acelity Holdings, Inc. , Medical Equipment, Deal Details 10
Asset Purchase 10
Acelity to Acquire Assets of Crawford Healthcare 10
Acelity Acquires Rights to SNaP Therapy System from Spiracur 11
Acelity Acquires Rights for Revolve System from GID 12
Partnerships 13
Acelity Enters into Co-Marketing Agreement with GHD GesundHeits 13
Systagenix Wound Management Enters Into Distribution Agreement With sorbion 14
MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 15
Equity Offering 16
Acelity Withdraws IPO of Shares 16
Debt Offering 17
Acelity Prices Private Placement of Notes for USD1.75 Billion 17
Acelity Raises USD190 Million in Private Placement of Additional 7.875% Notes Due 2021 18
Acelity Raises USD400 Million in Private Placement of 7.875% Notes Due 2021 19
Asset Transactions 20
Scapa Healthcare Acquires Systagenix Manufacturing Facility from Acelity 20
Scapa Healthcare to Acquire Gargrave Facility from Acelity 21
Acquisition 22
Allergan Acquires LifeCell from Acelity for USD2.9 Billion 22
Kinetic Concepts Completes Acquisition Of Systagenix From One Equity Partners For US$485 Million 24
Systagenix Acquires O2 Insights 26
Acelity Holdings, Inc. – Key Competitors 27
Acelity Holdings, Inc. – Key Employees 28
Acelity Holdings, Inc. – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Acelity Holdings, Inc. , Medical Equipment, Key Facts 2
Acelity Holdings, Inc. , Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Acelity Holdings, Inc. , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acelity Holdings, Inc. , Medical Equipment Deals By Type, 2012 to YTD 2018 6
Acelity Holdings, Inc. , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acelity Holdings, Inc. , Deals By Market, 2012 to YTD 2018 8
Acelity Holdings, Inc. , Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Acelity to Acquire Assets of Crawford Healthcare 10
Acelity Acquires Rights to SNaP Therapy System from Spiracur 11
Acelity Acquires Rights for Revolve System from GID 12
Acelity Enters into Co-Marketing Agreement with GHD GesundHeits 13
Systagenix Wound Management Enters Into Distribution Agreement With sorbion 14
MiMedx Enters Into Distribution Agreement With Systagenix Wound Management For EpiFix 15
Acelity Withdraws IPO of Shares 16
Acelity Prices Private Placement of Notes for USD1.75 Billion 17
Acelity Raises USD190 Million in Private Placement of Additional 7.875% Notes Due 2021 18
Acelity Raises USD400 Million in Private Placement of 7.875% Notes Due 2021 19
Scapa Healthcare Acquires Systagenix Manufacturing Facility from Acelity 20
Scapa Healthcare to Acquire Gargrave Facility from Acelity 21
Allergan Acquires LifeCell from Acelity for USD2.9 Billion 22
Kinetic Concepts Completes Acquisition Of Systagenix From One Equity Partners For US$485 Million 24
Systagenix Acquires O2 Insights 26
Acelity Holdings, Inc. , Key Competitors 27
Acelity Holdings, Inc. , Key Employees 28
Acelity Holdings, Inc. , Subsidiaries 29

List of Figures
Acelity Holdings, Inc. , Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Acelity Holdings, Inc. , Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Acelity Holdings, Inc. , Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Acelity Holdings, Inc. , Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Acelity Holdings, Inc. , Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acelity Holdings, Inc. , Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Acelity Holdings, Inc. , Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acelity Holdings, Inc. , Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Acelity Holdings, Inc.:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cargolux Airlines International S.A.:企業の戦略・SWOT・財務情報
    Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report Summary Cargolux Airlines International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • PT Bio Farma:製薬・医療:M&Aディール及び事業提携情報
    Summary PT Bio Farma (Bio Farma) is a manufacturer and supplier of vaccines, sera, and biological and diagnostics products. The company offers products such as DTP-hep B vaccine, DTP vaccine, DT vaccine, TT vaccine, polio vaccine, measles vaccine and BCG vaccine. It also offers biott vaccine for the …
  • TerSera Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TerSera Therapeutics LLC (TerSera Therapeutics) is a pharmaceutical company that develops of specialty pharmaceutical products. The company offers ergotamine tartrate sublingual tablets, goserelin acetate implant, zoladex, and zoladex la. It develops products in the therapeutic areas of alle …
  • Dongbu Corporation:企業の戦略・SWOT・財務情報
    Dongbu Corporation - Strategy, SWOT and Corporate Finance Report Summary Dongbu Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • Torrent Pharmaceuticals Ltd (TORNTPHARM):製薬・医療:M&Aディール及び事業提携情報
    Summary Torrent Pharmaceuticals Ltd (Torrent) manufactures and markets branded and unbranded generic pharmaceuticals. It provides products in cardiovascular, central nervous system, gastro-intestinal, diabetology, anti-infective and pain management segments. Also, the company has presence in nephrol …
  • Asarina Pharma AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Asarina Pharma AB (Asarina Pharma), formerly Umecrine Mood AB, a subsidiary of Umecrine AB, is a sepranolone product developer. The company offers discovery, development and commercialization of novel treatments for women suffering from premenstrual dysphoric disorder and other menstrual cyc …
  • Bioton SA (BIO):企業の戦略的SWOT分析
    Bioton SA (BIO) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • K&H Bank Zrt:企業の戦略・SWOT・財務情報
    K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report Summary K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Avadel Pharmaceuticals Plc (AVDL):医療機器:M&Aディール及び事業提携情報
    Summary Avadel Pharmaceuticals Plc (Avadel), formerly Flamel Technologies SA is a specialty pharmaceutical company, which develops and commercializes drugs for allergy, asthma, central nervous system (CNS) (narcolepsy), pain, respiratory diseases and diabetes. The company’s products are built on its …
  • Services Group of America:企業の戦略・SWOT・財務分析
    Services Group of America - Strategy, SWOT and Corporate Finance Report Summary Services Group of America - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • Aliancys AG:企業の戦略的SWOT分析
    Aliancys AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • U.S. Energy Corp (USEG):企業の財務・戦略的SWOT分析
    Summary U.S. Energy Corp (US Energy) is an oil and gas company that offers exploration, development and production of oil and natural gas properties. The company provides maintenance of mineral properties. It operates its oil and gas prospects located in the Williston Basin of North Dakota, the Eagl …
  • CanBas Co Ltd (4575)-製薬・医療分野:企業M&A・提携分析
    Summary CanBas Co Ltd (CanBas) is a clinical stage biopharmaceutical company that provides drugs. The company discovers and develops of novel therapeutics in the field of oncology targeting the cell cycle. It product under development is CBP501, a modified synthetic peptide enhancing the efficacy of …
  • Town Health International Medical Group Ltd (3886):企業の財務・戦略的SWOT分析
    Summary Town Health International Medical Group Ltd (THIMGL), formerly Town Health International Investments Ltd, a subsidiary of Hong Kong Health Check and Medical Diagnostic Group Ltd, is a healthcare service provider. The organization offers medical platform, chain clinics, specialty centres, man …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • EnPro Industries Inc (NPO):企業の財務・戦略的SWOT分析
    Summary EnPro Industries Inc (EnPro) is a diversified company that offers engineering solutions. The company designs, develops, manufactures and markets proprietary engineered industrial products. It provides commercial vehicle wheel-end components. EnPro offers sealing solutions for a wide range of …
  • Sam’s West Inc:企業の戦略的SWOT分析
    Sam's West Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Impresario Entertainment and Hospitality Pvt., Ltd.:企業の戦略・SWOT・財務情報
    Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Impresario Entertainment and Hospitality Pvt., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆